Skip to main content

Latest News

RELEASE: Legislation Introduced to Protect Patients in Recovery

Insuring Safety in Recovery (AB 1158) will require minimum insurance coverage, higher standards and reporting of hospitalizations and deaths

SACRAMENTO - In order to protect the safety of patients recovering from alcohol and substance use, Assemblywoman Cottie Petrie-Norris, in collaboration with Insurance Commissioner Ricardo Lara, introduced AB 1158 on Thursday, February 18, 2021. This bill will ensure that licensed drug abuse recovery and treatment facilities and recovery residences that contract with the government maintain minimum insurance coverage levels and higher standards to protect patients from abuse or injury. 

RELEASE: Immediate Relief for Small Businesses Quadrupled

$1.5BB Additional Relief Secured for Small Businesses & Nonprofits

SACRAMENTO – Governor Gavin Newsom, Senate President pro Tempore Toni G. Atkins and Assembly Speaker Anthony Rendon today announced a $9.6BB economic recovery package, including immediate actions to substantially increase aid for California small businesses & nonprofits who have been devastated by the COVID-19 pandemic (RELEASE).

RELEASE: What Others Are Saying About the Golden State Innovation Act

Investing in Life Sciences is an Investment in CA’s Future

SACRAMENTO – At a virtual press conference, Assemblymembers Cottie Petrie-Norris, Tom Daly, Kevin Mullin and Jacqui Irwin unveiled coalition support and legislative details of the Golden State Innovation Act. Assembly Bill 593 will restore the Research and Development (R&D) Tax Credit and Net Operating Loss (NOL) deductions for Life Sciences companies in California, at a pivotal point in the state’s pandemic response and recovery.
 

RELEASE: The Golden State Innovation Act Introduced

Securing California’s Role as the Nation’s Leader in Life Sciences & Setting CA on the Road to Recovery

SACRAMENTO – The Golden State Innovation Act of 2021 (AB 593) has been introduced to fuel job growth and innovation through the restoration of the Research and Development (R&D) Tax Credit and Net Operating Loss (NOL) deduction for Life Sciences companies in California.  AB 593 was introduced by Assemblymembers Cottie Petrie-Norris, Kevin Mullin, Tom Daly and Jacqui Irwin and is supported by a coalition of Life Science companies and patient-advocacy groups.